NCT05013450
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05013450
Title Dupilumab_Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Thomas Marron
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Tisch Cancer Institute, Mount Sinai Hospital New York New York 10003 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field